immune system
N |
• mice exhibit normal dendritic cell, T cell, B cell and macrophage populations in spleen, inguinal and mesenteric lymph nodes, Peyer's patch and thymus
|
• of activated dendritic cells in hapten-treated mice
|
• increased in hapten-treated mice
|
• slight increase in the proportion of splenic CD4+ T cells
(J:201008)
• lungs of SARS-CoV-infected mice exhibit a higher frequency and number of virus-specific CD4 T cells
(J:229035)
|
• lungs of SARS-CoV-infected mice exhibit a higher frequency and number of virus-specific CD8 T cells
|
• SARS-CoV-infected mice show augmented CD8 T cell cytolytic activity
• CD8 T cell responses are higher in the lungs of influenza A virus-infected mice at 10 days post infection
|
• hyperactive following LPS treatment
|
• mice exhibit a higher frequency and number of respiratory dendritic cells (rDCs) that migrate to the mediastinal lymph nodes (MLN) than wild-type mice
• SARS-CoV-infected middle-aged mice show a higher frequency and number of rDCs that migrate from lungs to MLN compared to infected wild-type mice
• influenza A virus-infected mice show a higher frequency and number of rDCs in the MLN at 18 hours post infection
|
• hapten-treated mice exhibit impaired resolution (determined by ear swelling, increased activated dendritic cells and increased effector T cells) compared with wild-type mice
• however, mice exhibit normal antigen uptake, recruitment and activation of skin dendritic cells migrating into the lymph nodes
|
• CD8 T cell from SARS-CoV-infected mice produce more IFN-gamma per cell
|
• from bone marrow-derived dendritic cells in response to suboptimal LPS treatment
|
• from bone marrow-derived dendritic cells in response to suboptimal LPS treatment
|
• middle-aged mice show decreased susceptibility to infection with SARS-CoV MA15
|
• more than 80% of middle-aged mice infected with SARS-CoV MA15 survive the infection compared to 0% survival in controls
• however, mice infected with the PR8 strain of influenza A virus
|
mortality/aging
• more than 80% of middle-aged mice infected with SARS-CoV MA15 survive the infection compared to 0% survival in controls
• however, mice infected with the PR8 strain of influenza A virus
|
homeostasis/metabolism
• decreased arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid in lymph nodes
|
• middle-aged, but not young, mice show lower levels of arachidonic acid
• middle-aged mice infected with SARS-CoV exhibit lower levels of free polyunsaturated fatty acids, arachidonic acid, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) in the lungs than controls
|
hematopoietic system
• mice exhibit a higher frequency and number of respiratory dendritic cells (rDCs) that migrate to the mediastinal lymph nodes (MLN) than wild-type mice
• SARS-CoV-infected middle-aged mice show a higher frequency and number of rDCs that migrate from lungs to MLN compared to infected wild-type mice
• influenza A virus-infected mice show a higher frequency and number of rDCs in the MLN at 18 hours post infection
|
• of activated dendritic cells in hapten-treated mice
|
• increased in hapten-treated mice
|
• slight increase in the proportion of splenic CD4+ T cells
(J:201008)
• lungs of SARS-CoV-infected mice exhibit a higher frequency and number of virus-specific CD4 T cells
(J:229035)
|
• lungs of SARS-CoV-infected mice exhibit a higher frequency and number of virus-specific CD8 T cells
|
• SARS-CoV-infected mice show augmented CD8 T cell cytolytic activity
• CD8 T cell responses are higher in the lungs of influenza A virus-infected mice at 10 days post infection
|
cellular
• mice exhibit a higher frequency and number of respiratory dendritic cells (rDCs) that migrate to the mediastinal lymph nodes (MLN) than wild-type mice
• SARS-CoV-infected middle-aged mice show a higher frequency and number of rDCs that migrate from lungs to MLN compared to infected wild-type mice
• influenza A virus-infected mice show a higher frequency and number of rDCs in the MLN at 18 hours post infection
|